Records of data processing activity for the Union Product Database
Submitted by Anonymous (not verified) on 1 April 2026 - 15:30
Records of data processing activity for the Union Product Database
Policy 82: Union Product Database (UPD) Access Policy - Veterinary Medicinal Products
Submitted by Anonymous (not verified) on 1 April 2026 - 15:30
Policy 82: Union Product Database (UPD) Access Policy - Veterinary Medicinal Products
European Medicines Agency’s data protection notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise
Submitted by Anonymous (not verified) on 1 April 2026 - 15:25
European Medicines Agency’s data protection notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise
Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 March 2026
Submitted by Anonymous (not verified) on 1 April 2026 - 15:16
Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 March 2026
Management Board meeting: 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, 12 March 2026
Submitted by Anonymous (not verified) on 1 April 2026 - 15:10
Management Board meeting: 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, 12 March 2026
Orphan medical devices regular process: Guide for applicants
Submitted by Anonymous (not verified) on 1 April 2026 - 14:19
Orphan medical devices regular process: Guide for applicants
Orphan medical devices regular process: 2026 timetable
Submitted by Anonymous (not verified) on 1 April 2026 - 14:18
Orphan medical devices regular process: 2026 timetable
Clinical advice request: Template for applicants
Submitted by Anonymous (not verified) on 1 April 2026 - 14:17
Clinical advice request: Template for applicants
Orphan status request: Template for applicants
Submitted by Anonymous (not verified) on 1 April 2026 - 14:16
Orphan status request: Template for applicants
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 40, Status: Authorised
Submitted by Anonymous (not verified) on 1 April 2026 - 13:38
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 40, Status: Authorised